Matthew Jones

Matthew Jones

Company: NextRNA tx

Job title: Head Of Platform Technology


Panel Discussion – Revolutionizing RNA Assays to Characterize the Mechanism of Action for Advancing RNA Targeted Drug Development 11:00 am

Comparing different assay and screening approaches which the field is currently using to better understand the mechanism of action How to optimize current assays to better understand the mechanism of action? How to utilize phenotypic methods to delve into the underlying mechanism?Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.